4.7 Review

Matrices and scaffolds for DNA delivery in tissue engineering

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 59, 期 4-5, 页码 292-307

出版社

ELSEVIER
DOI: 10.1016/j.addr.2007.03.017

关键词

gene therapy; regenerative medicine; biomaterials

资金

  1. NIBIB NIH HHS [R01 EB005678-01A1, R01 EB003806-03, R01 EB005678, R01 EB005678-02, R01 EB003806] Funding Source: Medline
  2. NIGMS NIH HHS [R01 GM066830-04, R01 GM066830-05, R01 GM066830] Funding Source: Medline

向作者/读者索取更多资源

Regenerative medicine aims to create functional tissue replacements, typically through creating a controlled environment that promotes and directs the differentiation of stem or progenitor cells, either endogenous or transplanted. Scaffolds serve a central role in many strategies by providing the means to control the local environment. Gene delivery from the scaffold represents a versatile approach to manipulating the local environment for directing cell function. Research at the interface of biomaterials, gene therapy, and drug delivery has identified several design parameters for the vector and the biomaterial scaffold that must be satisfied. Progress has been made towards achieving gene delivery within a tissue engineering scaffold, though the design principles for the materials and vectors that produce efficient delivery require further development. Nevertheless, these advances in obtaining transgene expression with the scaffold have created opportunities to develop greater control of either delivery or expression and to identify the best practices for promoting tissue formation. Strategies to achieve controlled, localized expression within the tissue engineering scaffold will have broad application to the regeneration of many tissues, with great promise for clinical therapies. (c) 2007 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据